showhide navigation
View all »

Hot Topics

9-valent HPV Vaccine – Info & Guidance from CDC


A 9-valent human papillomavirus (HPV) vaccine (Gardasil 9, Merck & Co., Inc) was licensed for use in females and males in the United States in December 2014. 1,2,3,4 9-valent HPV vaccine is the third HPV vaccine licensed by the Food and Drug Administration (FDA); the other vaccines are bivalent HPV vaccine, licensed for use in females, and quadrivalent HPV vaccine, licensed for use in females and males. The information here summarizes some of the recommendations included in the Policy Note and provides additional guidance for issues that were not addressed in the Policy Note but are likely to arise during the transition from quadrivalent HPV vaccine to 9-valent HPV vaccine.

View CDC Information Guide ยป